2025-08-28T14:31:48-05:00 2024-12-31 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2024-01-01 043809491 CLINICAL RESEARCH FORUM INC CLIN 2023671176 2001 K ST NW 300 WASHINGTON DC 20006 ANDREA VAN HOOK EXECUTIVE DIRECTOR 2023671176 2025-08-28 1 1 P01608821 4108840220 2024 2025-03-06 01:10:19Z ANDREA VAN HOOK 2001 K ST NW 300 WASHINGTON DC 20006 472166 0 X WWW.CLINICALRESEARCHFORUM.ORG X 2005 DE TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 16 16 0 17 0 0 23000 32500 408478 417582 34040 22084 0 0 465518 472166 17500 17500 0 0 0 0 0 0 0 528716 474411 546216 491911 -80698 -19745 1080307 1125533 171000 214973 909307 910560 X TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 0 0 151701 17500 TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS - THE TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS HONOR OUTSTANDING ACCOMPLISHMENTS AND MAJOR ADVANCES RESULTING FROM THE NATION'S INVESTMENT IN RESEARCH TO BENEFIT THE HEALTH AND WELFARE OF ITS CITIZENS. 49702 408500 MEMBERSHIP - THE MEMBERSHIP SERVICES INCLUDES DUES INVOICING AND PROCESSING AND DATABASE UPDATES OF ORGANIZATIONAL MEMBERS AND THEIR TEAMS SO THAT THEY CAN ACCESS THEIR BENEFITS, REGISTER FOR EVENTS, JOIN NEW MEMBER ORIENTATION, AND ACCESS COMMITTEE AND VOLUNTEER SUPPORT. 44999 ADVOCACY - THE COALITION FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) IS THE UNIFIED VOICE OF THE CLINICAL AND TRANSLATIONAL SCIENCE RESEARCH COMMUNITY, OF WHICH THE CLINICAL RESEARCH FORUM IS A MEMBER. STARTED AS A COALITION OF ORGANIZATIONS WITH A SHARED MISSION TO SUPPORT CLINICAL AND TRANSLATIONAL SCIENCE, CCTS HAS GROWN INTO A NATIONWIDE GRASSROOTS NETWORK OF DEDICATED INDIVIDUALS WHO WORK TOGETHER TO EDUCATE CONGRESS AND THE ADMINISTRATION ABOUT THE VALUE AND IMPORTANCE OF FEDERAL CLINICAL AND TRANSLATIONAL RESEARCH AND RESEARCH TRAINING AND CAREER DEVELOPMENT ACTIVITIES. 33453 82 ANNUAL MEETING - THE SENIOR LEADERSHIP MEETING IS AN ANNUAL CONVENING OF SENIOR LEADERS FROM ACADEMIC HEALTH CENTER MEMBER INSTITUTIONS. THIS FOCUSED, INTIMATE MEETING INCLUDES AN ADVOCACY AND POLICY UPDATE, INVITED SPEAKERS FROM RELEVANT GOVERNMENT AGENCIES, AND A STRATEGIC PLANNING DISCUSSION FOR THE ORGANIZATION. 9000 IT ROUNDTABLE - THE CLINICAL RESEARCH FORUM CONSIDERS THE INTEGRATION OF INFORMATION TECHNOLOGY (IT) AND CLINICAL RESEARCH A HIGH PRIORITY FOR ITS MEMBERS. THE IT ROUNDTABLE WAS INITIATED IN 2005 AND HAS CONTINUED TO BE ONE OF THE FORUM'S MOST ENGAGING INITIATIVES. ROUNDTABLE MEETINGS PROVIDE A VENUE FOR ACADEMIC HEALTH CENTER LEADERS TO SHARE EXPERIENCES AND WORK WITH VENDORS TO ADDRESS KEY IT ISSUES IN CLINICAL RESEARCH SUCH AS THE INTERFACE OF CLINICAL SERVICES AND CLINICAL RESEARCH DATA, WAREHOUSING, DATA SECURITY, ELECTRONIC HEALTH RECORD PLATFORMS, AND GOVERNANCE. 33453 9082 279855 0 0 0 1 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 14 0 1 0 0 0 0 0 0 0 0 0 X 16 16 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 X SMITHBUCKLIN CORPORATION 2023671176 2001 K ST NW 300 WASHINGTON DC 20006 X HARRY P SELKER MD MSPH CHAIR 1.00 X X 0 0 0 HERBERT PARDES MD VICE-CHAIR UNTIL APRIL 1.00 X X 0 0 0 WILLIAM L LOWE JR MD SECRETARY/TREASURER 1.00 X X 0 0 0 EMMA MEAGHER MD DIRECTOR UNTIL MAY, THEN VICE CHAIR 1.00 X X 0 0 0 E ALBERT REECE MD PHD MBA DIRECTOR UNTIL MAY, THEN VICE CHAIR 1.00 X X 0 0 0 BARRY S COLLER MD DIRECTOR 1.00 X 0 0 0 ANNE B CURTIS MD DIRECTOR 1.00 X 0 0 0 PAMELA DAVIS MD PHD DIRECTOR 1.00 X 0 0 0 MAURIZIO FAVA MD DIRECTOR 1.00 X 0 0 0 HARRY B GREENBERG MD DIRECTOR 1.00 X 0 0 0 RACHEL HESS MD MS DIRECTOR 1.00 X 0 0 0 RAINU KAUSHAL MD DIRECTOR 1.00 X 0 0 0 ARTHUR H RUBENSTEIN MBBCH DIRECTOR 1.00 X 0 0 0 ANANTHA SHEKHAR MD PHD DIRECTOR 1.00 X 0 0 0 DUANE MITCHELL MD PHD DIRECTOR 1.00 X 0 0 0 GARY ELLIOT ROSENTHAL MD FACP DIRECTOR AS OF JULY 1.00 X 0 0 0 SHARON M MOE MD DIRECTOR AS OF JULY 1.00 X 0 0 0 ANDREA VAN HOOK EXECUTIVE DIRECTOR 15.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 MANAGEMENT/ED COMPENSATION 371122 1 32500 32500 MEMBERSHIP DUES 900099 408500 408500 IT ROUNDTABLE DUES/REG 900099 9000 9000 CAREER CENTER 900099 82 82 417582 22084 22084 472166 417582 0 22084 17500 17500 330345 165464 164881 638 638 11300 11300 43407 43407 23589 15483 8106 14174 1824 12350 16094 15831 263 20346 20346 9958 9958 DUES AND SUBSCRIPTIONS 3778 3778 LICENSES, FEES AND TAXE 681 681 MISCELLANEOUS 101 101 491911 279855 212056 0 398398 383193 3064 3755 24168 675090 718172 1080307 1125533 10175 171000 204798 171000 214973 X 841203 851405 68104 59155 909307 910560 1080307 1125533 -19745 20998 0 X X 0 1 X 1 0 1 0 0 68104 -1449 7500 59155 66257 9347 7500 68104 86974 -13217 7500 66257 89287 5187 7500 86974 87806 8981 7500 89287 1.00000 0 0 0 X PART V, LINE 4: A FUND WITH DONOR RESTRICTIONS HAS BEEN ESTABLISHED TO SUPPORT THE HERBERT PARDES CLINICAL RESEARCH EXCELLENCE AWARD. PER THE DONOR'S INSTRUCTIONS, THE CONTRIBUTED FUNDS AND RELATED EARNINGS THEREON ARE REQUIRED TO BE SEGREGATED IN A SEPARATE INVESTMENT ACCOUNT TO PAY A $7,500 ANNUAL AWARD. HOWEVER, IN THE EVENT THE INVESTED FUNDS DO NOT GENERATE SUFFICIENT INCOME IN A GIVEN YEAR, THE ORGANIZATION IS AUTHORIZED TO EXPEND ADDITIONAL FUNDS FROM THE RELATED INVESTMENTS TO MAKE THE AWARD. PART X, LINE 2: THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. 1 THE HERBERT PARDES CLINICAL RESEARCH EXCELLENCE AWARD 1 7500 DISTINGUISHED CLINICAL RESEARCH ACHIEVEMENT AWARDS 2 10000 PART I, LINE 2: CRF AWARDS TEN ACHIEVEMENT AWARDS TO TOP RESEARCHERS. THE TOP THREE AWARDEES RECEIVE MONETARY RECOGNITION, THE REMAINING SEVEN DO NOT. AWARDS ARE RECOGNITIONS OF ACHIEVEMENT, SO NO MONITORING IS NEEDED. FORM 990, PART VI, SECTION A, LINE 3 THE CLINICAL RESEARCH FORUM, INC. (CRF) HAS ENTERED INTO A MANAGEMENT CONTRACT WITH SMITHBUCKLIN CORPORATION. UNDER THE TERMS OF THIS AGREEMENT, CRF MAKES PAYMENTS TO SMITHBUCKLIN WHICH COVER STAFF SALARIES, EXECUTIVE DIRECTOR, AND OTHER OVERHEAD EXPENSES. THE FEES INCURRED BY CRF DURING 2024 WERE $331,345 FOR THE FOLLOWING: EXECUTIVE MANAGEMENT - $90,153, MEMBERSHIP AND OPERATIONS SERVICES, EVENT SERVICES, MARKETING AND COMMUNICATIONS SERVICES, FINANCIAL MANAGEMENT AND ACCOUNTING SERVICES, INFORMATION TECHNOLOGY SERVICES, PROJECT PRINTING AND SUPPORT, CREATIVE AND DESIGN SERVICES, AND PROMOTIONAL PRODUCTS AND SUPPORT. SMITHBUCKLIN'S PERFORMANCE UNDER THIS AGREEMENT IS MONITORED BY THE BOARD OF CRF. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION'S MEMBERS SHALL BE ACADEMIC HEALTH CENTERS THAT ARE INTERESTED IN PARTICIPATING IN THE ACTIVITIES OF THE CORPORATION OR SUPPORTING ITS MISSION AND PURPOSE AND THAT PAY DUES IN ACCORDANCE WITH THE CORPORATION'S REQUIREMENTS. FORM 990, PART VI, SECTION A, LINE 7A DIRECTORS SHALL BE ELECTED BY A PLURALITY OF THE VOTES CAST TO A THREE (3) YEAR TERM BY THE CRF MEMBERS AT THE ANNUAL MEETING OR AT ANY SPECIAL MEETING HELD IN LIEU THEREOF, FROM A SLATE OF ONE (1) OR MORE CANDIDATES SELECTED BY THE NOMINATING COMMITTEE FOR EACH OPEN POSITION. FORM 990, PART VI, SECTION A, LINE 7B EACH CRF MEMBER SHALL HAVE AN EQUAL VOTE AT EVERY MEETING OF THE MEMBERS. UNLESS OTHERWISE PROVIDED BY LAW, THE CERTIFICATE OF INCORPORATION OR THE BY-LAWS, AN AFFIRMATIVE VOTE OF THE MAJORITY OF THE CRF MEMBERS PRESENT AND ENTITLED TO VOTE SHALL DECIDE EVERY QUESTION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY MANAGEMENT AND PROVIDED TO THE FINANCE/AUDIT COMMITTEE AND BOARD OF DIRECTORS BEFORE IT IS SIGNED AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD'S FINANCE COMMITTEE IS RESPONSIBLE FOR ENFORCING COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION DID NOT CHANGE ITS AUDIT OVERSIGHT PROCESS OR SELECTION OF AN INDEPENDENT AUDITOR PROCESS DURING THE TAX YEAR. CLINICAL RESEARCH FOUNDATION INC 2001 K STREET NW 3RD FLOOR WASHINGTON DC 20006 020773588 FURTHERING EFFECTIVE TRANSLATIONAL RESEARCH DE 501(C)(3) LINE 7 CLINICAL RESEARCH FORUM INC 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0